ctrl K

Price Alert

Akebia Therapeutics Inc. (AKBA)

NASDAQ: AKBA · Real-Time Price · USD

3.24

-0.05 (-1.52%)

At close: Aug 15, 2025, 3:59 PM

3.25

0.31%

After-hours: Aug 15, 2025, 07:55 PM EDT

Akebia Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	51.87M	42.92M	90.47M	149.8M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	2.7M	2.04M
Other Long-Term Assets	37.38M	12.42M	5.37M	49.75M
Receivables	34.37M	39.29M	41.06M	51.58M
Inventory	16.24M	15.69M	21.76M	38.2M
Other Current Assets	7.32M	20.24M	17.25M	4.31M
Total Current Assets	113.83M	118.15M	184.95M	272.01M
Property-Plant & Equipment	10.42M	16.05M	34.37M	40.61M
Goodwill & Intangibles	59.04M	95.09M	127.14M	163.18M
Total Long-Term Assets	106.84M	123.55M	166.88M	253.54M
Total Assets	220.67M	241.7M	351.83M	525.55M
Account Payables	15.18M	14.63M	18.02M	33.59M
Deferred Revenue	n/a	n/a	3.74M	20.91M
Short-Term Debt	n/a	19.55M	32M	97.54M
Other Current Liabilities	56.54M	18.26M	52.53M	31.18M
Total Current Liabilities	80.91M	99.87M	124.76M	256.49M
Long-Term Debt	38.69M	71.2M	91.56M	n/a
Other Long-Term Liabilities	146.7M	48.98M	57.47M	139.11M
Total Long-Term Liabilities	188.94M	172.42M	217.73M	192.6M
Total Liabilities	269.86M	272.29M	342.49M	449.09M
Total Debt	47.64M	104.18M	99.78M	136.05M
Common Stock	2K	2K	2K	1K
Retained Earnings	-1.68B	-1.61B	-1.55B	-1.46B
Comprehensive Income	6K	6K	6K	6K
Shareholders Equity	-49.19M	-30.58M	9.34M	76.46M
Total Investments	n/a	1.65M	2.7M	2.04M